Nuvilex, Inc. (Public - PINK:NVLX) operates independently and through wholly owned subsidiaries, that brings to market scientifically derived products designed to improve the health and well-being. It is a biotechnology and life technology company. Nuvilex manufactures, directly or indirectly through independent contractors Cinnergen, Cinnechol, Infinitink (and related private label ink products), and Talysn Scar Cream. The Company is also engaged in the research and development of Oraphyte, a non-toxic, biodegradable nematocide for use on turfgrass and crops, as well as Citroxin, is a natural, eco-friendly surface cleaner. Sales of I-Boost Immune Bars were discontinued in May 2009. The subsidiaries of the Company include Knock-Out Technologies, Ltd., MedElite, Inc., Cinnergen, Inc., I-Boost, Inc., Cinnechol Inc., Freedom-2 GmbH, Berlin, Freedom-2 Creditor Partners, Freedom-2 Holdings, Inc, Freedom-2, Inc., Exceptional Equipment and Ink Supply Company, Inc.